Cerenome (PSTV) Net Margin Growth (3y) (2014 - 2026)
Cerenome (PSTV) Net Margin Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -374.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -44.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | -389.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -13,815.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7,793.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 9,934.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -11,156.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 31,387.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -5,319.00 |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - | -211,324.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27,852.00 |
| Dec 31, 2025 | 407,267.00 |
| Sep 30, 2025 | 683,263.00 |
| Mar 31, 2019 | 30,294.00 |
| Dec 31, 2018 | 3,577.00 |
| Sep 30, 2018 | -65,100.00 |
| Jun 30, 2018 | -48,383.00 |
| Mar 31, 2018 | 185,624.00 |
| Dec 31, 2017 | -96,775.00 |
| Sep 30, 2017 | 78,244.00 |
| Jun 30, 2017 | 64,077.00 |
| Mar 31, 2017 | -26,775.00 |
| Dec 31, 2016 | -617.00 |
| Sep 30, 2016 | -14,531.00 |
| Jun 30, 2016 | -7,067.00 |
| Mar 31, 2016 | 13,439.00 |
| Dec 31, 2015 | -10,969.00 |
| Sep 30, 2015 | 113,588.00 |
| Jun 30, 2015 | 72,773.00 |
| Mar 31, 2015 | -188,445.00 |